147 related articles for article (PubMed ID: 38006035)
1. Development of A Standardized Opsonophagocytosis Killing Assay for Group B
Leung S; Collett CF; Allen L; Lim S; Maniatis P; Bolcen SJ; Alston B; Patel PY; Kwatra G; Hall T; Thomas S; Taylor S; Le Doare K; Gorringe A
Vaccines (Basel); 2023 Nov; 11(11):. PubMed ID: 38006035
[TBL] [Abstract][Full Text] [Related]
2. Interlaboratory comparison of a multiplex immunoassay that measures human serum IgG antibodies against six-group B streptococcus polysaccharides.
Le Doare K; Gaylord MA; Anderson AS; Andrews N; Baker CJ; Bolcen S; Felek A; Giardina PC; Grube CD; Hall T; Hallis B; Izu A; Madhi SA; Maniatis P; Matheson M; Mawas F; McKeen A; Rhodes J; Alston B; Patel P; Schrag S; Simon R; Tan CY; Taylor S; Kwatra G; Gorringe A
Hum Vaccin Immunother; 2024 Dec; 20(1):2330138. PubMed ID: 38608170
[TBL] [Abstract][Full Text] [Related]
3. Development of a multiplexed opsonophagocytic killing assay (MOPA) for group B Streptococcus.
Choi MJ; Noh JY; Cheong HJ; Kim WJ; Lin SM; Zhi Y; Lim JH; Lim S; Seo HS; Song JY
Hum Vaccin Immunother; 2018 Jan; 14(1):67-73. PubMed ID: 28933634
[TBL] [Abstract][Full Text] [Related]
4. The Protective Value of Maternal Group B Streptococcus Antibodies: Quantitative and Functional Analysis of Naturally Acquired Responses to Capsular Polysaccharides and Pilus Proteins in European Maternal Sera.
Fabbrini M; Rigat F; Rinaudo CD; Passalaqua I; Khacheh S; Creti R; Baldassarri L; Carboni F; Anderloni G; Rosini R; Maione D; Grandi G; Telford JL; Margarit I
Clin Infect Dis; 2016 Sep; 63(6):746-753. PubMed ID: 27402816
[TBL] [Abstract][Full Text] [Related]
5. Novel Multiplex Immunoassays for Quantification of IgG against Group B
Buffi G; Galletti B; Stella M; Proietti D; Balducci E; Romano MR; Mori E; Fabbrini M; Giuliani MM; Berti F; Margarit I
mSphere; 2019 Aug; 4(4):. PubMed ID: 31391276
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a 6-plex Luminex-based assay for measuring human serum antibodies to group B streptococcus capsular polysaccharides.
Gaylord MA; Larrier M; Giordano-Schmidt D; Grube CD; Singh S; Nguyen HH; McKeen A; Tan CY; Anderson AS; Kalina WV; Pavliakova D; Giardina PC
Hum Vaccin Immunother; 2024 Dec; 20(1):2311480. PubMed ID: 38608171
[TBL] [Abstract][Full Text] [Related]
7. Threshold-free estimation of functional antibody titers of a group B streptococcus opsonophagocytic killing assay.
Moraschini L; Passalacqua I; Fabbrini M; Margarit Y Ros I; Rigat F
Pharm Stat; 2015; 14(3):189-97. PubMed ID: 25689055
[TBL] [Abstract][Full Text] [Related]
8. Role of L-ficolin/mannose-binding lectin-associated serine protease complexes in the opsonophagocytosis of type III group B streptococci.
Aoyagi Y; Adderson EE; Min JG; Matsushita M; Fujita T; Takahashi S; Okuwaki Y; Bohnsack JF
J Immunol; 2005 Jan; 174(1):418-25. PubMed ID: 15611266
[TBL] [Abstract][Full Text] [Related]
9. L-ficolin and capsular polysaccharide-specific IgG in cord serum contribute synergistically to opsonophagocytic killing of serotype III and V group B streptococci.
Fujieda M; Aoyagi Y; Matsubara K; Takeuchi Y; Fujimaki W; Matsushita M; Bohnsack JF; Takahashi S
Infect Immun; 2012 Jun; 80(6):2053-60. PubMed ID: 22451515
[TBL] [Abstract][Full Text] [Related]
10. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.
Kasper DL; Paoletti LC; Wessels MR; Guttormsen HK; Carey VJ; Jennings HJ; Baker CJ
J Clin Invest; 1996 Nov; 98(10):2308-14. PubMed ID: 8941648
[TBL] [Abstract][Full Text] [Related]
11. Sublingual immunisation with GBS serotype III capsular polysaccharide-tetanus toxoid conjugate vaccine induces systemic and mucosal antibody responses which are opsonophagocytic and inhibit GBS colonisation of vaginal epithelial cells.
Deifallah Yousif M; Felek A; Saydam M; Wilson S; Murdan S; Mawas F
Vaccine; 2022 Oct; 40(42):6055-6063. PubMed ID: 36096970
[TBL] [Abstract][Full Text] [Related]
12. Functional activity of maternal and cord antibodies elicited by an investigational group B Streptococcus trivalent glycoconjugate vaccine in pregnant women.
Fabbrini M; Rigat F; Tuscano G; Chiarot E; Donders G; Devlieger R; Filippini S; Frigimelica E; Forte P; Wittke F; Halperin SA; Slobod K; Grandi G; Margarit I
J Infect; 2018 May; 76(5):449-456. PubMed ID: 29374589
[TBL] [Abstract][Full Text] [Related]
13. Systematic review of the clinical development of group B streptococcus serotype-specific capsular polysaccharide-based vaccines.
Dzanibe S; Madhi SA
Expert Rev Vaccines; 2018 Jul; 17(7):635-651. PubMed ID: 29961350
[TBL] [Abstract][Full Text] [Related]
14. Development of an opsonophagocytic killing assay for group a streptococcus.
Jones S; Moreland NJ; Zancolli M; Raynes J; Loh JMS; Smeesters PR; Sriskandan S; Carapetis JR; Fraser JD; Goldblatt D
Vaccine; 2018 Jun; 36(26):3756-3763. PubMed ID: 29776751
[TBL] [Abstract][Full Text] [Related]
15. Healthy elderly people lack neutrophil-mediated functional activity to type V group B Streptococcus.
Amaya RA; Baker CJ; Keitel WA; Edwards MS
J Am Geriatr Soc; 2004 Jan; 52(1):46-50. PubMed ID: 14687314
[TBL] [Abstract][Full Text] [Related]
16. Immune response of healthy women to 2 different group B streptococcal type V capsular polysaccharide-protein conjugate vaccines.
Baker CJ; Paoletti LC; Rench MA; Guttormsen HK; Edwards MS; Kasper DL
J Infect Dis; 2004 Mar; 189(6):1103-12. PubMed ID: 14999615
[TBL] [Abstract][Full Text] [Related]
17. A new flow-cytometry-based opsonophagocytosis assay for the rapid measurement of functional antibody levels against Group B Streptococcus.
Fabbrini M; Sammicheli C; Margarit I; Maione D; Grandi G; Giuliani MM; Mori E; Nuti S
J Immunol Methods; 2012 Apr; 378(1-2):11-9. PubMed ID: 22309986
[TBL] [Abstract][Full Text] [Related]
18. Preparation and preclinical evaluation of experimental group B streptococcus type III polysaccharide-cholera toxin B subunit conjugate vaccine for intranasal immunization.
Shen X; Lagergård T; Yang Y; Lindblad M; Fredriksson M; Holmgren J
Vaccine; 2000 Nov; 19(7-8):850-61. PubMed ID: 11115709
[TBL] [Abstract][Full Text] [Related]
19. Multiplex opsonophagocytosis assay (MOPA): a useful tool for the monitoring of the 7-valent pneumococcal conjugate vaccine.
Bogaert D; Sluijter M; De Groot R; Hermans PW
Vaccine; 2004 Sep; 22(29-30):4014-20. PubMed ID: 15364451
[TBL] [Abstract][Full Text] [Related]
20. Development and Validation of Enzyme-Linked Immunosorbent Assay for Group B Streptococcal Polysaccharide Vaccine.
Jang AY; Choi MJ; Zhi Y; Ji HJ; Noh JY; Yoon JG; Cheong HJ; Kim WJ; Seo HS; Song JY
Vaccines (Basel); 2021 May; 9(6):. PubMed ID: 34064299
[No Abstract] [Full Text] [Related]
[Next] [New Search]
